First year after head and neck cancer: Quality of life
First year after head and neck cancer: Quality of life
复制标题
DOI:
10.1200/jco.1999.17.1.352
复制
发表时间:
1999-01-01
影响因子:
45.3
通讯作者:
Abemayor, E
中科院分区:
文献类型:
--
作者:
Gritz, ER;Carmack, CL;Abemayor, E
Purpose:Treatment regimens for head and neck cancer patients profoundly affect several quality-of-life domains. Rehabilitative needs have been identified through cross-sectional analyser; however, few studies have prospectively assessed quality of life, included assessment of psychosocial variables, and identified predictors of long-term follow-up.Participants and Methods: The present study addresses these limitations through a prospective assessment of 105 patients with a newly diagnosed first primary squamous cell carcinoma of the oral cavity, pharynx, or larynx. Participants were enrolled onto a larger randomized controlled trial comparing a provider-delivered smoking cessation intervention with a usual-care-advice control condition. Participants completed a battery of self-report measures after diagnosis and before treatment and additional quality-of-life instruments at 1 and 12 months after initial smoking cessation advice.Results: Participants displayed improvements at 12 months in functional status (P = .006) and in the areas of eating, diet, and speech; however, the latter three represent areas of continued dysfunction, and the changes were not statistically significant. Despite these improvements, patients reported a decline in certain quality-of-life domains, including marital (P = .002) and sexual functioning (P = .017), as well as an increase in alcohol use (P < .001). Predictors of quality of life at 12 months included treatment type, the Vigor subscale of the Profile of Mood States instrument, and quality-of-life scores obtained I month after initial smoking cessation advice.Conclusion: Results reinforce the need for rehabilitation management through the integration of psychologic and behavioral interventions in medical follow-up.J Clin Oncol 17:352-360. (C) 1999 by American Society of Clinical Oncology.